With US Respiratory Pipeline Unlocked, Cipla Wants Lung Leadership

Also Sets Out Ambitions For China And Brazil

 
• By Anju Ghangurde

Cipla sees an incremental revenue opportunity of up to $500m for its US franchise by fiscal 2025 and expects to propel growth with strong execution of its complex generics pipeline. The company is also beginning to “lay the blueprint” in China and Brazil, it said at the J.P. Morgan Healthcare Conference.

Lungs operation puzzle concept: hands of surgeon with surgical instruments (tools) perform lungs surgery as a result of respiratory disease, pneumonia, tuberculosis, bronchitis, asthma, lung abscess
Cipla Lays Out Respiratory Ambitions At JPM • Source: Shutterstock

More from Strategy

More from Business